Advances in Osteoporosis: Emerging Approaches to Manage Male Patients

Released On
March 9, 2022

Expires On
March 9, 2023

Media Type

Completion Time
60 minutes

Bone Health, Endocrinology, Geriatric Medicine, Osteoporosis, Primary Care,

Primary Care

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Amgen Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is directed toward primary care clinicians, geriatricians, endocrinologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of male patients with or at risk of developing osteoporosis.

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of osteoporosis in men, with a forward-looking perspective on how the use of new and novel agents in men might impact clinical practice. An overview of male osteoporosis, as well as current and emerging treatment strategies, will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the disease burden of osteoporosis on male patients
  • Review guideline recommendations for the management of male patients with osteoporosis
  • Assess clinical trial data for currently available therapies for osteoporosis in male patients
  • Evaluate clinical trial data for emerging agents to treat osteoporosis in male patients




John P. Bilezikian, MD, PhD (hon)

Silberberg Professor of Medicine
Vice-Chair, Department of Medicine, InternationaI Education and Research
Vagelos College of Physicians and Surgeons
Columbia University
New York, NY


E. Michael Lewiecki, MD

Director, New Mexico Clinical Research & Osteoporosis Center
Director, Bone Health TeleECHO
University of New Mexico Health Sciences Center
Albuquerque, NM


Physician Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Disclosures of Conflicts of Interest

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

John P. Bilezikian, MD, PhD (hon), has no relevant financial relationships with ineligible companies.

E. Michael Lewiecki, MD
  • Grant/research support: Amgen, Radius
  • Consultant: Amgen

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.